Your browser doesn't support javascript.
loading
The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer.
Noble, Sian M; Garfield, Kirsty; Lane, J Athene; Metcalfe, Chris; Davis, Michael; Walsh, Eleanor I; Martin, Richard M; Turner, Emma L; Peters, Tim J; Thorn, Joanna C; Mason, Malcolm; Bollina, Prasad; Catto, James W F; Doherty, Alan; Gnanapragasam, Vincent; Hughes, Owen; Kockelbergh, Roger; Kynaston, Howard; Paul, Alan; Paez, Edgar; Rosario, Derek J; Rowe, Edward; Oxley, Jon; Staffurth, John; Neal, David E; Hamdy, Freddie C; Donovan, Jenny L.
Affiliation
  • Noble SM; Bristol Medical School, University of Bristol, Bristol, UK. s.m.noble@bristol.ac.uk.
  • Garfield K; Bristol Medical School, University of Bristol, Bristol, UK.
  • Lane JA; Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.
  • Metcalfe C; Bristol Medical School, University of Bristol, Bristol, UK.
  • Davis M; Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.
  • Walsh EI; Bristol Medical School, University of Bristol, Bristol, UK.
  • Martin RM; Bristol Randomised Trials Collaboration, Bristol Trials Centre, University of Bristol, Bristol, UK.
  • Turner EL; Bristol Medical School, University of Bristol, Bristol, UK.
  • Peters TJ; Bristol Medical School, University of Bristol, Bristol, UK.
  • Thorn JC; Bristol Medical School, University of Bristol, Bristol, UK.
  • Mason M; National Institute for Health Research, Bristol Biomedical Research Centre, University of Bristol, Bristol, UK.
  • Bollina P; Bristol Medical School, University of Bristol, Bristol, UK.
  • Catto JWF; Bristol Medical School, University of Bristol, Bristol, UK.
  • Doherty A; Bristol Medical School, University of Bristol, Bristol, UK.
  • Gnanapragasam V; The School of Medicine, University of Cardiff, Cardiff, UK.
  • Hughes O; Department of Urology and Surgery, Western General Hospital, Edinburgh, UK.
  • Kockelbergh R; The Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • Kynaston H; Department of Urology, Queen Elizabeth Hospital, Birmingham, UK.
  • Paul A; The Academic Urology Group, University of Cambridge, Cambridge, UK.
  • Paez E; Cambridge Urology Translational Research and Clinical Trials Office, Cambridge, UK.
  • Rosario DJ; Department of Urology, Cardiff and Vale University Health Board, Cardiff, UK.
  • Rowe E; Department of Urology, University Hospitals Leicester, Leicester, UK.
  • Oxley J; The School of Medicine, University of Cardiff, Cardiff, UK.
  • Staffurth J; Department of Urology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Neal DE; Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK.
  • Hamdy FC; Department of Urology, Sheffield Teaching Hospitals, Sheffield, UK.
  • Donovan JL; Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK.
Br J Cancer ; 123(7): 1063-1070, 2020 09.
Article in En | MEDLINE | ID: mdl-32669672

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido